Search research articles
Contact Us
Filters
Showing results (1-10 of 87) with videos related to
Page
of 9
Sort By:
Central Nervous System Agents in Medicinal Chemistry
|
October 31, 2025
PREFACE
Sadayuki Hashioka
CNS & Neurological Disorders Drug Targets
|
July 15, 2024
Glia as a New Target for Therapeutic Actions of Electroconvulsive Therapy
Sadayuki Hashioka
CNS & Neurological Disorders Drug Targets
|
September 5, 2020
Glia and Glial Growth Factors as New Therapeutic Targets in Neuropsychiatric Disorders
Sadayuki Hashioka
Medicine, Science, and the Law
|
April 21, 2020
Tailgating (<i>aori-unten</i>): A recent major social issue in Japan
Ken Inoue, Sadayuki Hashioka, Haruo Takeshita
Current Neuropharmacology
|
November 12, 2020
Glia-Driven Neuroinflammation and Systemic Inflammation in Alzheimer's Disease
Sadayuki Hashioka, Zhou Wu, Andis Klegeris
Asia-Pacific Journal of Public Health
|
July 9, 2020
Risk of an Increase in Suicide Rates Associated With Economic Downturn due to COVID-19 Pandemic
Ken Inoue, Sadayuki Hashioka, Noriyuki Kawano
Experimental Neurology
|
February 24, 2009
Proton pump inhibitors exert anti-inflammatory effects and decrease human microglial and monocytic THP-1 cell neurotoxicity
Sadayuki Hashioka, Andis Klegeris, Patrick L McGeer
Journal of Neuroinflammation
|
June 1, 2012
The histone deacetylase inhibitor suberoylanilide hydroxamic acid attenuates human astrocyte neurotoxicity induced by interferon-γ
Sadayuki Hashioka, Andis Klegeris, Patrick L McGeer
Glia
|
March 2, 2011
Proton pump inhibitors reduce interferon-γ-induced neurotoxicity and STAT3 phosphorylation of human astrocytes
Sadayuki Hashioka, Andis Klegeris, Patrick L McGeer
Current Alzheimer Research
|
November 18, 2021
Diversity and Regulation of Astrocyte Neurotoxicity in Alzheimer's Disease
Sadayuki Hashioka, James G McLarnon, Andis Klegeris
Page
of 9
Search research articles
Search
Showing results (1-10 of 87) with videos related to
Sort By:
Page
of 9
Central Nervous System Agents in Medicinal Chemistry
|
October 31, 2025
PREFACE
Sadayuki Hashioka
CNS & Neurological Disorders Drug Targets
|
July 15, 2024
Glia as a New Target for Therapeutic Actions of Electroconvulsive Therapy
Sadayuki Hashioka
CNS & Neurological Disorders Drug Targets
|
September 5, 2020
Glia and Glial Growth Factors as New Therapeutic Targets in Neuropsychiatric Disorders
Sadayuki Hashioka
Medicine, Science, and the Law
|
April 21, 2020
Tailgating (<i>aori-unten</i>): A recent major social issue in Japan
Ken Inoue, Sadayuki Hashioka, Haruo Takeshita
Current Neuropharmacology
|
November 12, 2020
Glia-Driven Neuroinflammation and Systemic Inflammation in Alzheimer's Disease
Sadayuki Hashioka, Zhou Wu, Andis Klegeris
Asia-Pacific Journal of Public Health
|
July 9, 2020
Risk of an Increase in Suicide Rates Associated With Economic Downturn due to COVID-19 Pandemic
Ken Inoue, Sadayuki Hashioka, Noriyuki Kawano
Experimental Neurology
|
February 24, 2009
Proton pump inhibitors exert anti-inflammatory effects and decrease human microglial and monocytic THP-1 cell neurotoxicity
Sadayuki Hashioka, Andis Klegeris, Patrick L McGeer
Journal of Neuroinflammation
|
June 1, 2012
The histone deacetylase inhibitor suberoylanilide hydroxamic acid attenuates human astrocyte neurotoxicity induced by interferon-γ
Sadayuki Hashioka, Andis Klegeris, Patrick L McGeer
Glia
|
March 2, 2011
Proton pump inhibitors reduce interferon-γ-induced neurotoxicity and STAT3 phosphorylation of human astrocytes
Sadayuki Hashioka, Andis Klegeris, Patrick L McGeer
Current Alzheimer Research
|
November 18, 2021
Diversity and Regulation of Astrocyte Neurotoxicity in Alzheimer's Disease
Sadayuki Hashioka, James G McLarnon, Andis Klegeris
Page
of 9